# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001140361-26-013365
Filing Date
2026-04-06
Accepted
2026-04-06 17:01:20
Documents
1
Period of Report
2025-12-31
Effectiveness Date
2026-04-06

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | ef20069834_ars.pdf | ARS | 28493229
| Complete submission text file | 0001140361-26-013365.txt |  | 39247914

Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-36407 | Film No.: 26841993
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)